Evidence map›Paper›PMID 32508950›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Bibliometric Analysis of the Results of Cardio-Oncology Research.

Kangkang Wei, Jiangquan Liao, Jiangmeng Chang, Xiaoqiong Zhang, Ming Chen, Jinhang Du

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kangkang WeiGraduate School Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-3441-9761
Jiangquan LiaoDepartment of Cardiology of Integrated Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-8445-0433
Jiangmeng ChangGraduate School Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-6353-0557
Xiaoqiong ZhangGraduate School Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0001-6193-856X
Ming ChenGraduate School Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0003-1132-5380
Jinhang DuDepartment of Cardiology of Integrated Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China.ORCID https://orcid.org/0000-0001-9807-3440

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the development of cardio-oncology, summarize the research achievements, and provide proposals for its future research.

methodsThe web of science database was used to search for "cardio-oncology" and "oncocardiology" related articles from the beginning of the database (1970) to April 5, 2019. Excel 2016 and Cytoscape were used to analyze the trend of cardio-oncology research.

resultsA total of 356 articles were obtained. The number of articles has grown rapidly in recent years. Cardiac injury caused by tumor therapy was a research hotspot (

conclusionsCardio-oncology has been developing rapidly and receiving a large amount of research efforts in recent years. Most articles on cardio-oncology were published by the authors from the United States (44%) and Italy (17%), while other countries need to pay more attention to cardio-oncology. As an independent discipline, cardio-oncology is certainly in need of significant progress, but it has formed a basic framework, which has obtained many leading theories and meaningful achievements in diagnostic criteria, diagnostic methods, prevention and treatment, mechanism research, and influencing factor. Cardiac injury of tumor drugs has always been a research hotspot in this discipline, and there is still a lot of research space. The research about detection methods of cardiotoxicity and preventive drugs is gradually increasing. Basic research lags behind, and many mechanisms are still unclear.

Identifiers

PMID32508950
PMCPMC7244983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.